YOSHINAGA Mitsukane,KUWADA Takeshi,MIYAKOSHI Naoki,ISHIZAKA Tomoko,WAKASUGI Daisuke,SHIROKAWA Shin-ichi,HATTORI Nobutaka,SHIMAZAKI Youichi,SHIROKAWA Sh
申请号：
SI201230542
公开号：
SI2772482T1
申请日:
2012.10.25
申请国别(地区):
SI
年份:
2016
代理人:
摘要：
The present invention provides agents for treating or preventing diseases such as mood disorder, anxiety disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastrointestinal disease, drug addiction, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, head injury, inflammation, immune-related disease, alopecia, and so forth. Specifically, the invention provides azole derivatives represented by general formula (I), or pharmaceutically acceptable salts thereof that have an antagonistic action against the arginine-vasopressin (AVP) V1b receptor:
